In other countries
The same active substances on other registers, the same brand first.
- DayvigoBrazil · Eisai Laboratórios LtdaSame brand
- Dayvigo Film-Coated Tablet 10MGSingapore · 10 mg · tablet, film coated · Eisai (Singapore) Pte. LTD.Same brand
- Dayvigo Film-Coated Tablet 5MGSingapore · 5 mg · tablet, film coated · Eisai (Singapore) Pte. LTD.Same brand
- DayvigoUnited States · 10MG, 5MG · tablet · Eisai INCSame brand
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Lemborexant
- Strength
- 10 MG
- Dosage form
- Tablet
- Route
- Oral
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 6 Nov 2020
- Registration
- DIN 02507374
- Marketing authorisation holder
- Eisai Limited
- ATC code
- N05CJ02
- Group
- Nervous system
- Supply
- PRESCRIPTION